Hasil Pencarian - Manon Vounckx

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Successful treatment of MAP2K1 mutant stage IV-M1d melanoma with trametinib plus low-dose dabrafenib: a case report

    Successful treatment of MAP2K1 mutant stage IV-M1d melanoma with trametinib plus low-dose dabrafenib: a case report oleh Iris Dirven, Evan Calliauw, Gil Awada, Manon Vounckx, Jolien I. Kessels, Bart Neyns

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Unraveling the spectrum of inflammatory myofibroblastic tumors in the lung: A comprehensive case series highlighting endobronchial, pleural, and lung parenchymal tumorsCentral MessagePerspective

    Unraveling the spectrum of inflammatory myofibroblastic tumors in the lung: A comprehensive case series highlighting endobronchial, pleural, and lung parenchymal tumorsCentral Mess... oleh Manon Vounckx, MD, Yanina J.L. Jansen, PhD, MD, Sharareh Fadaei, MD, Caroline Geers, MD, Vincent De Pauw, MD, Dirk Smets, MD

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma

    Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous... oleh Bart Neyns, Julia Katharina Schwarze, Karen Willard-Gallo, Ramses Forsyth, Jens Tijtgat, Sandra Tuyaerts, Ivan Van Riet, Steven Raeymaeckers, Xenia Geeraerts, Latoya Stevens, Manon Vounckx, Iris Dirven, Anais Boisson

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    694 A randomized phase II clinical trial of SBRT and pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c(BDCA-1)+/CD141(BDCA-3)+ myeloid dendritic cells in solid tumors

    694 A randomized phase II clinical trial of SBRT and pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c(BDCA-1)+/CD141(BDCA-3)+ myeloid dendritic cells in sol... oleh Bart Neyns, Bart Ilsen, Jens Tijtgat, Frederik Vandenbroucke, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, Xenia Geeraerts, Latoya Stevens, Manon Vounckx, Iris Dirven, Steven Raemaeckers, Selma Ben Mustapha, Jens Van Loon, Lore Decoster, Mark De Ridder

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: